Peers of ADC Therapeutics SA (ADCT)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by EBITDA over the last 12 months. A common way to compare companies with different amounts of debt.
Latest EV/EBITDA
-3.72x
As of Sep 29, 2026
Beyond EV/EBITDA, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/EBITDA |
|---|---|
| Sep 29, 2026 | -3.72x |
| Sep 28, 2026 | -3.76x |
| Sep 25, 2026 | -3.77x |
| Sep 24, 2026 | -3.80x |
| Sep 23, 2026 | -3.82x |
| Sep 22, 2026 | -3.72x |
| Sep 21, 2026 | -3.57x |
| Sep 18, 2026 | -3.48x |
EV/EBITDA = Enterprise Value / EBITDA (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/EBITDA is widely used because it removes the effects of financing and non-cash accounting items.
Read the general EV/EBITDA definition, formula, and analyst usage guide.
EV/EBITDA guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison